In order to further its expansion in the Middle East, Singapore’s Phaidros Healthcare has entered into an exclusive distribution agreement with Al-Rawasi Al-Saedah Trading, a company which is part of the A’Alam Al Dawa group. The deal will include the majority of Phaidros’s products with focus on its Women’s Health and Paediatric range.
Phaidros is a young healthcare company focusing on the development and commercialization of strongly differentiated non-prescription drugs and medical devices, especially in the therapeutic areas reproductive medicine and intimate care.
The company has offices in Singapore and Berlin.
About A’Alam Al Dawa Group
A’Alam Al Dawa was established in 1995 as a Yemeni limited company with a vision to serve the Yemeni market with
Its business is grouped around Pharmaceuticals, Raw Materials and Agricultural products
A’Alam serves customers such as the Ministry of Health, the Ministry of Defense, Government hospitals, private clinics, pharmacies and laboratories